Total Payments
$148,627
2024 Payments
$67,825
Companies
21
Transactions
134
Medicare Patients
86
Medicare Billing
$18,821
Payment Breakdown by Category
Consulting$71,181 (47.9%)
Other$45,370 (30.5%)
Travel$27,021 (18.2%)
Food & Beverage$5,055 (3.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $71,181 | 38 | 47.9% |
| Honoraria | $31,000 | 4 | 20.9% |
| Travel and Lodging | $27,021 | 34 | 18.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,370 | 6 | 9.7% |
| Food and Beverage | $5,055 | 52 | 3.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABIOMED | $47,995 | 16 | $0 (2024) |
| Edwards Lifesciences Corporation | $25,215 | 52 | $0 (2024) |
| Astute Medical, Inc. | $20,076 | 10 | $0 (2018) |
| Trevena, Inc. | $12,916 | 5 | $0 (2022) |
| Fresenius USA Marketing, Inc. | $11,129 | 9 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $7,270 | 11 | $0 (2024) |
| Chugai Pharmaceutical Co., Ltd. | $4,453 | 3 | $0 (2024) |
| Astellas Pharma Inc | $4,290 | 3 | $0 (2022) |
| AstraZeneca UK Limited | $3,759 | 1 | $0 (2024) |
| NxStage Medical, Inc. | $3,529 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $67,825 | 40 | ABIOMED ($47,995) |
| 2023 | $10,605 | 9 | Alexion Pharmaceuticals, Inc. ($4,737) |
| 2022 | $19,740 | 14 | Trevena, Inc. ($12,916) |
| 2021 | $7,215 | 9 | C. R. Bard, Inc. & Subsidiaries ($2,970) |
| 2020 | $2,000 | 1 | Edwards Lifesciences Corporation ($2,000) |
| 2019 | $2,341 | 18 | Edwards Lifesciences Corporation ($2,328) |
| 2018 | $14,702 | 22 | Astute Medical, Inc. ($9,900) |
| 2017 | $24,200 | 21 | Edwards Lifesciences Corporation ($11,619) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Becton, Dickinson and Company | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 11/26/2024 | Chugai Pharmaceutical Co., Ltd. | — | Consulting Fee | Cash or cash equivalent | $2,420.00 | General |
| 11/26/2024 | Chugai Pharmaceutical Co., Ltd. | — | Food and Beverage | In-kind items and services | $218.40 | General |
| 11/20/2024 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $3,759.00 | General |
| 11/15/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Consulting Fee | Cash or cash equivalent | $742.50 | General |
| Category: Rare Disease | ||||||
| 11/07/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.52 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/04/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $1.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/21/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $112.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/20/2024 | Becton, Dickinson and Company | — | Food and Beverage | In-kind items and services | $77.67 | General |
| 10/20/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $63.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $43.36 | General |
| Category: Rare Disease | ||||||
| 10/19/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $58.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/08/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Consulting Fee | Cash or cash equivalent | $880.00 | General |
| Category: Pain Management | ||||||
| 10/02/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $28.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $11,617.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | ABIOMED | Impella (Device) | Honoraria | Cash or cash equivalent | $10,200.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $4,744.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $259.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | ABIOMED | Impella (Device) | Travel and Lodging | Cash or cash equivalent | $120.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/19/2024 | Edwards Lifesciences Corporation | — | Travel and Lodging | Cash or cash equivalent | $146.43 | General |
| 08/05/2024 | Edwards Lifesciences Corporation | — | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| 07/04/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $160.57 | General |
| 06/27/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $15.95 | General |
| 06/06/2024 | ABIOMED | Impella (Device) | Honoraria | Cash or cash equivalent | $17,400.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/06/2024 | ABIOMED | Impella (Device) | Travel and Lodging | In-kind items and services | $1,351.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 21 | 40 | $66,360 | $6,604 |
| 2022 | 2 | 33 | 44 | $45,342 | $5,515 |
| 2021 | 2 | 32 | 46 | $53,832 | $6,702 |
Total Patients
86
Total Services
130
Medicare Billing
$18,821
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 21 | 40 | $66,360 | $6,604 | 10.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 14 | 22 | $33,176 | $3,818 | 11.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 19 | 22 | $12,166 | $1,697 | 13.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 20 | 30 | $45,240 | $5,347 | 11.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 16 | $8,592 | $1,355 | 15.8% |
About Dr. Andrew Shaw, MD
Dr. Andrew Shaw, MD is a Anesthesiology healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619051539.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Shaw, MD has received a total of $148,627 in payments from pharmaceutical and medical device companies, with $67,825 received in 2024. These payments were reported across 134 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($71,181).
As a Medicare-enrolled provider, Shaw has provided services to 86 Medicare beneficiaries, totaling 130 services with total Medicare billing of $18,821. Data is available for 3 years (2021–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Anesthesiology
- Other Specialties Anesthesiology
- Location Cleveland, OH
- Active Since 10/25/2006
- Last Updated 01/06/2021
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1619051539
Products in Payments
- Impella (Device) $47,995
- OLINVYK (Drug) $12,916
- NephroCheck Test (Device) $10,176
- Nephrocheck (Device) $9,900
- ULTOMIRIS (Biological) $4,636
- NOVALUNG SYSTEM (Device) $3,224
- The Swan-Ganz Catheter (Device) $2,500
- System One (Device) $2,405
- Invia Motion Endure (Device) $1,500
- HemoSphere advanced monitoring platform (Device) $987.86
- Exparel (Drug) $880.00
- EV1000 Clinical Platform (Device) $837.79
- NXSTAGE SYSTEM ONE (Device) $700.00
- INVOS (Device) $120.88
- GIAPREZA (Drug) $46.90
- PROVENGE (Drug) $33.52
- Xofigo (Drug) $17.68
- SOMATULINE DEPOT (Drug) $13.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Cleveland
Sabry Ayad, M.d, M.D
Anesthesiology — Payments: $632,587
Anesthesiology $632,587
Dr. Edwin Avery, Md, MD
Anesthesiology — Payments: $376,267
Anesthesiology $376,267
Daniel Sessler, M.d, M.D
Anesthesiology — Payments: $342,890
Anesthesiology $342,890
Peter Schoenwald, Md, MD
Anesthesiology — Payments: $140,951
Anesthesiology $140,951
Hesham Elsharkawy, M.d, M.D
Anesthesiology — Payments: $134,336
Anesthesiology $134,336
Basem Abdelmalak, Md, MD
Anesthesiology — Payments: $131,740
Anesthesiology $131,740